FDA Approvals and Earnings Beats Propel Specialized US-Listed FirmsGlobal Report·Jul 26 at 04:14 AMREPL+1.12%CELC+0.97%
Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies | ERNA Stock NewsStockTitan·Jul 24 at 12:20 AMERNA-5.54%
Ernexa Therapeutics climbs 7% during regular trading to $6.47US Stock Market Update·Jul 15 at 12:52 PMERNA-5.54%
Dow Gains Over 150 Points; Morgan Stanley Profit Tops Viewsbenzinga_article·Jul 15 at 08:43 AM.DJI-2.19%ERNA-5.54%
Ernexa Therapeutics surges 40% intraday after 88% premarket jumpUS Stock Market Update·Jul 15 at 08:41 AMERNA-5.54%
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga_article·Jul 15 at 07:05 AMVTAK+1.00%NXTC-7.38%
Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry | ERNA Stock NewsStockTitan·Jul 14 at 10:50 PMERNA-5.54%
Ernexa Therapeutics SVP of Finance Sandra Gurrola resigns effective July 3PUBT·Jun 26 at 03:31 PMERNA-5.54%
